Cutting Edge Research for Exploration of Biomolecules for Gemcitabine-Based Chemo-Resistant Advanced Bile Duct Cancer: From Basic Study to Clinical Trial

Bile duct cancer (BDC) has been identified as a highly aggressive cancer arising from epithelial cells of the bile duct, including intrahepatic, perihilar, and extrahepatic [...]

Guardado en:

Detalles Bibliográficos
Autores principales:	Chiao-En Wu, Chun-Nan Yeh
Formato:	article
Lenguaje:	EN
Publicado:	MDPI AG 2021
Materias:	n/a Microbiology QR1-502
Acceso en línea:	https://doaj.org/article/658c7a8280db49c9b9c046215a06a456
Etiquetas:	Agregar Etiqueta Sin Etiquetas, Sea el primero en etiquetar este registro!

id	oai:doaj.org-article:658c7a8280db49c9b9c046215a06a456
record_format	dspace
spelling	oai:doaj.org-article:658c7a8280db49c9b9c046215a06a4562021-11-25T16:52:58ZCutting Edge Research for Exploration of Biomolecules for Gemcitabine-Based Chemo-Resistant Advanced Bile Duct Cancer: From Basic Study to Clinical Trial10.3390/biom111116262218-273Xhttps://doaj.org/article/658c7a8280db49c9b9c046215a06a4562021-11-01T00:00:00Zhttps://www.mdpi.com/2218-273X/11/11/1626https://doaj.org/toc/2218-273XBile duct cancer (BDC) has been identified as a highly aggressive cancer arising from epithelial cells of the bile duct, including intrahepatic, perihilar, and extrahepatic [...]Chiao-En WuChun-Nan YehMDPI AGarticlen/aMicrobiologyQR1-502ENBiomolecules, Vol 11, Iss 1626, p 1626 (2021)
institution	DOAJ
collection	DOAJ
language	EN
topic	n/a Microbiology QR1-502
spellingShingle	n/a Microbiology QR1-502 Chiao-En Wu Chun-Nan Yeh Cutting Edge Research for Exploration of Biomolecules for Gemcitabine-Based Chemo-Resistant Advanced Bile Duct Cancer: From Basic Study to Clinical Trial
description	Bile duct cancer (BDC) has been identified as a highly aggressive cancer arising from epithelial cells of the bile duct, including intrahepatic, perihilar, and extrahepatic [...]
format	article
author	Chiao-En Wu Chun-Nan Yeh
author_facet	Chiao-En Wu Chun-Nan Yeh
author_sort	Chiao-En Wu
title	Cutting Edge Research for Exploration of Biomolecules for Gemcitabine-Based Chemo-Resistant Advanced Bile Duct Cancer: From Basic Study to Clinical Trial
title_short	Cutting Edge Research for Exploration of Biomolecules for Gemcitabine-Based Chemo-Resistant Advanced Bile Duct Cancer: From Basic Study to Clinical Trial
title_full	Cutting Edge Research for Exploration of Biomolecules for Gemcitabine-Based Chemo-Resistant Advanced Bile Duct Cancer: From Basic Study to Clinical Trial
title_fullStr	Cutting Edge Research for Exploration of Biomolecules for Gemcitabine-Based Chemo-Resistant Advanced Bile Duct Cancer: From Basic Study to Clinical Trial
title_full_unstemmed	Cutting Edge Research for Exploration of Biomolecules for Gemcitabine-Based Chemo-Resistant Advanced Bile Duct Cancer: From Basic Study to Clinical Trial
title_sort	cutting edge research for exploration of biomolecules for gemcitabine-based chemo-resistant advanced bile duct cancer: from basic study to clinical trial
publisher	MDPI AG
publishDate	2021
url	https://doaj.org/article/658c7a8280db49c9b9c046215a06a456
work_keys_str_mv	AT chiaoenwu cuttingedgeresearchforexplorationofbiomoleculesforgemcitabinebasedchemoresistantadvancedbileductcancerfrombasicstudytoclinicaltrial AT chunnanyeh cuttingedgeresearchforexplorationofbiomoleculesforgemcitabinebasedchemoresistantadvancedbileductcancerfrombasicstudytoclinicaltrial
_version_	1718412900331159552

Cutting Edge Research for Exploration of Biomolecules for Gemcitabine-Based Chemo-Resistant Advanced Bile Duct Cancer: From Basic Study to Clinical Trial

Ejemplares similares